Vulkaniseringsvätska - Twice cycle parts — recall 0318/09
EU Safety Gate (RAPEX) · Sweden · 2009-03-13 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Produkten utgör en kemisk risk eftersom den innehåller 0,3 % toluen. Enligt begränsningsdirektivet 76/769/EEG får toluen, i lim avsett för försäljning till allmänheten, inte släppas ut på marknaden eller användas som ämne eller beståndsdel i beredningar i en koncentration som är lika med eller högre än 0,1 viktprocent. Toluen är klassificerat som reproduktionstoxiskt.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Voluntary withdrawal from the market by the retailer
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Rubber solution - Twice cycle parts
Risk Description (original English): The product poses a chemical risk because it contains 0.3% toluene. According to the Chemical Restrictions Directive 76/769/EEC, in adhesives intended for sale to the general public, toluene should not be placed on the market or used as a substance or constituent of preparations in a concentration equal to or higher than 0.1% by mass. Toluene is classified as toxic for reproduction.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.